Why Conatus Pharmaceuticals May Have the Answer to Liver Disease
Steven Mento, PhD on Advanced Therapy for Liver Disease
1:52 | Gastroenterology
Steven Mento, PhD, Co-Founder, President & CEO, Conatus Pharmaceuticals, introduces Conatus’s latest project, Emricasan, a therapy for acute catastrophic liver disease. With 2 billion people worldwide with liver disease, Dr. Mento urges physicians to be aware of the prevalence and importance of liver disease.
